Understanding Patient Experiences with Innovations in Heart Failure Care
了解心力衰竭护理创新的患者体验
基本信息
- 批准号:465780
- 负责人:
- 金额:$ 7.9万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Fellowship Programs
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-03-01 至 2024-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
TRANSFORM HF, a strategic initiative of the Ted Rogers Centre for Heart Research, aims to empower collaboration and patient-driven equitable care. To leverage this priority, three core projects will be pursued: 1) integrating surveys that assess patient o
TRANSFORM HF是Ted Rogers心脏研究中心的一项战略举措,旨在增强协作和患者驱动的公平护理。为了充分利用这一优先事项,将开展三个核心项目:1)整合评估患者健康状况的调查,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrason Sarah V其他文献
Lawrason Sarah V的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrason Sarah V', 18)}}的其他基金
Integrated heart failure care across complex health systems: Early lessons from the year 1 implementation of the Mid-West Toronto Ontario Health Team's demonstration project
跨复杂卫生系统的综合心力衰竭护理:安大略省中西部多伦多卫生团队示范项目实施第一年的早期经验教训
- 批准号:
495431 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
相似海外基金
Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
- 批准号:
502586 - 财政年份:2024
- 资助金额:
$ 7.9万 - 项目类别:
SBIR Phase II: In-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-proBNP monitoring system for heart failure treatment
SBIR II 期:用于心力衰竭治疗的可批量生产和工厂校准的可穿戴 NT-proBNP 监测系统的体内验证
- 批准号:
2335105 - 财政年份:2024
- 资助金额:
$ 7.9万 - 项目类别:
Cooperative Agreement
RAPHAEL - Integrating a Palliative Care Approach for Patients with Heart Failure
RAPHAEL - 为心力衰竭患者整合姑息治疗方法
- 批准号:
10112701 - 财政年份:2024
- 资助金额:
$ 7.9万 - 项目类别:
EU-Funded
Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure
值得信赖的人工智能,用于慢性心力衰竭的个性化风险评估
- 批准号:
10078557 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
EU-Funded
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
- 批准号:
491149 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Fellowship Programs
Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization
机器学习与传统统计模型预测急性心力衰竭住院后再入院的比较
- 批准号:
495410 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Exploratory research to elucidate the molecular mechanisms by which depression makes heart failure more severe and to reconstruct heart failure treatment strategies.
探索性研究旨在阐明抑郁症使心力衰竭更加严重的分子机制,并重建心力衰竭治疗策略。
- 批准号:
23K07507 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Advanced fluorescence spectroscopy to unravel functional oligomerization of a newly discovered Ca2+ channel and its role in heart failure.
先进的荧光光谱揭示了新发现的 Ca2 通道的功能性寡聚及其在心力衰竭中的作用。
- 批准号:
2885854 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Studentship
Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
- 批准号:
23K15167 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists